Sebnem Avsar Tuna has been appointed as General Manager for Novo Nordisk’s UK affiliate, succeeding Pinder Sahota, who stepped down in December 2024.

Sebnem began her pharmaceutical career in 1999 as a Medical Advisor with Santa Farma, a pharmaceutical company based in Istanbul, Turkey. She joined Novo Nordisk in 2000 and has since held various leadership roles, including General Manager of Novo Nordisk Turkey and Corporate Vice President of the Business Area Commonwealth of Independent States.

A medical doctor with global experience in medical, sales, and marketing, Sebnem most recently managed the company’s operations across South-East Asia, Oceania, India, Pakistan, and Iran as Senior Vice President of Region Asia Pacific.

Sebnem’s strategic vision and dedication have significantly contributed to Novo Nordisk’s growth and success in these regions. The company believes her appointment will strengthen their commitment to delivering effective treatments for serious chronic diseases to more patients across the UK.

Commenting on her appointment, Sebnem Avsar Tuna said: “I am honoured to take on the role of General Manager for Novo Nordisk UK. I am eager to collaborate with my colleagues here in the UK and ensure that our medicines reach those living with chronic conditions who need them most. My commitment is to lead with empathy, promote open dialogue, and inspire our team to excel in serving patients and stakeholders alike. I am excited to continue building on our legacy of leadership in healthcare and drive forward our mission of transforming bold ideas into reality through collaboration and excellence.”